Sfoglia per Rivista
Association of D-dimer levels with all-cause mortality in a healthy adult population: findings from the MOLI-SANI study.
2013-01-01 Di Castelnuovo, A; de Curtis, A; Costanzo, S; Persichillo, M; Olivieri, M; Zito, F; Donati, Mb; de Gaetano, G; Iacoviello, Licia; MOLI SANI Project, Investigators
Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: An analysis by the MPN QOL international working group
2017-01-01 Geyer, H. L.; Kosiorek, H.; Dueck, A. C.; Scherber, R.; Slot, S.; Zweegman, S.; te Boekhorst, P. A. W.; Senyak, Z.; Schouten, H. C.; Sackmann, F.; Fuentes, A. K.; Hernández-Maraver, D.; Pahl, H. L.; Griesshammer, M.; Stegelmann, F.; Döhner, K.; Lehmann, T.; Bonatz, K.; Reiter, A.; Boyer, F.; Etienne, G.; Ianotto, J. -C.; Ranta, D.; Roy, L.; Cahn, J. -Y.; Harrison, C. N.; Radia, D.; Muxi, P.; Maldonado, N.; Besses, C.; Cervantes, F.; Johansson, P. L.; Barbui, T.; Barosi, G.; Vannucchi, A. M.; Paoli, C.; Passamonti, F.; Andreasson, B.; Ferrari, M. L.; Rambaldi, A.; Samuelsson, J.; Cannon, K.; Birgegard, G.; Xiao, Z.; Xu, Z.; Zhang, Y.; Sun, X.; Xu, J.; Kiladjian, J. -J.; Zhang, P.; Gale, R. P.; Mesa, R. A.
Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patients
2001-01-01 Corso, A; Arcaini, L; Mangiacavalli, S; Astori, C; Orlandi, E; Lorenzi, A; Passamonti, Francesco; Klersy, C; Pascutto, C; Canevari Sciorati, A; Lazzarino, M.
Centralized cytogenetic analysis of pediatric acute leukemia: results of an italian collaborative experience
1997-01-01 Sainati, L.; Leszl, A.; Putti, Mc; Pasquali, Francesco; Maserati, Emanuela; Donti, E.; Venti, G.; Simi, P.; Giuliani, C.; Angioni, A.; Stella, M.; Montaldi, A.; Sessarego, M.; Zanesco, L.; Biondi, A.; Basso, G.
Chromosome anomalies as cause of congenital bone marrow failure syndromes
2015-01-01 Valli, Roberto; DE PAOLI, Elena; Montalbano, Giuseppe; Frattini, A; Vinti, L; Pasquali, Francesco; Locatelli, Franco; Maserati, Emanuela
La citogenetica e la genetica molecolare nelle sindromi mielodisplastiche
2005-01-01 Pasquali, Francesco
Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry.
2008-01-01 Imberti, D; Agnelli, G; Ageno, Walter; Moia, M; Palareti, G; Pistelli, R; Rossi, R; Verso, M; Master, Investigators
Clinical relevance of JAK2 (V617F) mutant allele burden
2009-01-01 Passamonti, Francesco; Rumi, E.
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06
2021-01-01 Caprioli, Chiara; Lussana, Federico; Salmoiraghi, Silvia; Cavagna, Roberta; Buklijas, Ksenija; Elidi, Lara; Zanghi', Pamela; Michelato, Anna; Delaini, Federica; Oldani, Elena; Intermesoli, Tamara; Grassi, Anna; Gianfaldoni, Giacomo; Mannelli, Francesco; Ferrero, Dario; Audisio, Ernesta; Terruzzi, Elisabetta; De Paoli, Lorella; Cattaneo, Chiara; Borlenghi, Erika; Cavattoni, Irene; Tajana, Monica; Scattolin, Anna Maria; Mattei, Daniele; Corradini, Paolo; Campiotti, Leonardo; Ciceri, Fabio; Bernardi, Massimo; Todisco, Elisabetta; Cortelezzi, Agostino; Falini, Brunangelo; Pavoni, Chiara; Bassan, Renato; Spinelli, Orietta; Rambaldi, Alessandro
CLINICAL SIGNIFICANCE OF END OF INDUCTION MINIMAL RESIDUAL DISEASE IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN COMPLETE REMISSION AFTER A SINGLE CHEMOTHERAPY COURSE
2017-01-01 Bassan, R; Masciulli, A; Intermesoli, T; Spinelli, O; Tosi, M; Pavoni, C; Audisio, E; Cattaneo, C; Fumagalli, M; Cassibba, V; Mattei, D; Romani, C; Cortelezzi, A; Ciceri, F; Scattolin, Am; Vitolo, U; Borlenghi, E; Gallamini, A; Depaoli, L; Campiotti, L; Bocchia, M; Di Bona, E; Oldani, E; Rambaldi, A
Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders.
2003-01-01 Passamonti, Francesco; Vanelli, L; Malabarba, L; Rumi, E; Pungolino, E; Malcovati, L; Pascutto, C; Morra, E; Lazzarino, M; Cazzola, M.
Clonal chromosome anomalies and propensity to myeloid malignancies in congenital amegakaryocytic thrombocytopenia (OMIM 604498)
2008-01-01 Maserati, Emanuela; Panarello, C.; Morerio, C.; Valli, Roberto; Pressato, Barbara; Patitucci, F.; Tassano, E.; Di Cesare Merlone, A.; Cugno, C.; Balduini, C. L.; LO CURTO, Francesco; Dufour, C.; Locatelli, F.; Pasquali, Francesco
Conceiving a hematopoietic stem cell donor: twenty-five years after our decision
2012-01-01 G. R., Burgio; Nespoli, Luigi; R., Maccario; A. P., Verri; P., Comoli; M., Zecca
COVID-19 pandemic affects the ability of negative D-dimer to identify venous thromboembolism patients at low risk of recurrence: insights from the Apidulcis study
2023-01-01 Palareti, G.; Legnani, C.; Poli, D.; Ageno, W.; Pengo, V.; Testa, S.; Tosetto, A.; Prandoni, P.
Cytoreductive therapy for patients with essential thrombocythemia at high risk of thromboembolic complications. The difficult choice of the optimal drug
2004-01-01 Passamonti, Francesco; Cazzola, M.
Deep sequencing reveals double mutations in cis of MPL exon 10 in myeloproliferative neoplasms
2011-01-01 Pietra, D; Brisci, A; Rumi, E; Boggi, S; Elena, C; Pietrelli, A; Bordoni, R; Ferrari, M; Passamonti, Francesco; De Bellis, G; Cremonesi, L; Cazzola, M.
EBVD and alternating MOPP/EBVD with or without localized field radiotherapy in advanced or unfavorably presenting Hodgkin's disease.
1996-01-01 Pogliani, Em; Deliliers, Gl; Baldini, L; Tosi, A; Butti, C; Chiorboli, O; Confalonieri, C; Fava, S; Giorgetti, Mc; Maioli, M; Maiolo, At; Marinoni, P; Montalbetti, Lorenzo; Mozzana, R; Pavia, G; Pinotti, G; Rossini, F; Vanoli, P; Venco, Achille; Cassi, E.
EFFICACY OF A IDARUBICIN, ETOPOSIDE AND INTERMEDIATE-DOSE CYTARABINE ARABINOSIDE AS SALVAGE THERAPY IN RELAPSING OR RESISTANT UNFAVORABLE LYMPHOMA
1998-01-01 Brusamolino, E; Passamonti, Francesco; Pagnucco, G; Castagnola, C; Lazzarino, M; Bernasconi, C.
EFFICACY OF PIPOBROMAN IN THE TREATMENT OF POLYCYTHEMIA VERA: LONG TERM RESULTS IN 163 PATIENTS
2000-01-01 Passamonti, Francesco; Brusamolino, E; Lazzarino, M; Barat, C; Klersy, C; Orlandi, E; Canevari, A; Castelli, G; Merante, S; Bernasconi, C.
Erythroleukaemia in early childhood associated with monosomy 7 and defective neutrophil chemotaxis
1982-01-01 Marchi, A.; Sacchi, F.; Ferro, P.; Rubbi, P.; Pasquali, Francesco
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Association of D-dimer levels with all-cause mortality in a healthy adult population: findings from the MOLI-SANI study. | 1-gen-2013 | Di Castelnuovo, A; de Curtis, A; Costanzo, S; Persichillo, M; Olivieri, M; Zito, F; Donati, Mb; de Gaetano, G; Iacoviello, Licia; MOLI SANI Project, Investigators | |
| Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: An analysis by the MPN QOL international working group | 1-gen-2017 | Geyer, H. L.; Kosiorek, H.; Dueck, A. C.; Scherber, R.; Slot, S.; Zweegman, S.; te Boekhorst, P. A. W.; Senyak, Z.; Schouten, H. C.; Sackmann, F.; Fuentes, A. K.; Hernández-Maraver, D.; Pahl, H. L.; Griesshammer, M.; Stegelmann, F.; Döhner, K.; Lehmann, T.; Bonatz, K.; Reiter, A.; Boyer, F.; Etienne, G.; Ianotto, J. -C.; Ranta, D.; Roy, L.; Cahn, J. -Y.; Harrison, C. N.; Radia, D.; Muxi, P.; Maldonado, N.; Besses, C.; Cervantes, F.; Johansson, P. L.; Barbui, T.; Barosi, G.; Vannucchi, A. M.; Paoli, C.; Passamonti, F.; Andreasson, B.; Ferrari, M. L.; Rambaldi, A.; Samuelsson, J.; Cannon, K.; Birgegard, G.; Xiao, Z.; Xu, Z.; Zhang, Y.; Sun, X.; Xu, J.; Kiladjian, J. -J.; Zhang, P.; Gale, R. P.; Mesa, R. A. | |
| Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patients | 1-gen-2001 | Corso, A; Arcaini, L; Mangiacavalli, S; Astori, C; Orlandi, E; Lorenzi, A; Passamonti, Francesco; Klersy, C; Pascutto, C; Canevari Sciorati, A; Lazzarino, M. | |
| Centralized cytogenetic analysis of pediatric acute leukemia: results of an italian collaborative experience | 1-gen-1997 | Sainati, L.; Leszl, A.; Putti, Mc; Pasquali, Francesco; Maserati, Emanuela; Donti, E.; Venti, G.; Simi, P.; Giuliani, C.; Angioni, A.; Stella, M.; Montaldi, A.; Sessarego, M.; Zanesco, L.; Biondi, A.; Basso, G. | |
| Chromosome anomalies as cause of congenital bone marrow failure syndromes | 1-gen-2015 | Valli, Roberto; DE PAOLI, Elena; Montalbano, Giuseppe; Frattini, A; Vinti, L; Pasquali, Francesco; Locatelli, Franco; Maserati, Emanuela | |
| La citogenetica e la genetica molecolare nelle sindromi mielodisplastiche | 1-gen-2005 | Pasquali, Francesco | |
| Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry. | 1-gen-2008 | Imberti, D; Agnelli, G; Ageno, Walter; Moia, M; Palareti, G; Pistelli, R; Rossi, R; Verso, M; Master, Investigators | |
| Clinical relevance of JAK2 (V617F) mutant allele burden | 1-gen-2009 | Passamonti, Francesco; Rumi, E. | |
| Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06 | 1-gen-2021 | Caprioli, Chiara; Lussana, Federico; Salmoiraghi, Silvia; Cavagna, Roberta; Buklijas, Ksenija; Elidi, Lara; Zanghi', Pamela; Michelato, Anna; Delaini, Federica; Oldani, Elena; Intermesoli, Tamara; Grassi, Anna; Gianfaldoni, Giacomo; Mannelli, Francesco; Ferrero, Dario; Audisio, Ernesta; Terruzzi, Elisabetta; De Paoli, Lorella; Cattaneo, Chiara; Borlenghi, Erika; Cavattoni, Irene; Tajana, Monica; Scattolin, Anna Maria; Mattei, Daniele; Corradini, Paolo; Campiotti, Leonardo; Ciceri, Fabio; Bernardi, Massimo; Todisco, Elisabetta; Cortelezzi, Agostino; Falini, Brunangelo; Pavoni, Chiara; Bassan, Renato; Spinelli, Orietta; Rambaldi, Alessandro | |
| CLINICAL SIGNIFICANCE OF END OF INDUCTION MINIMAL RESIDUAL DISEASE IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN COMPLETE REMISSION AFTER A SINGLE CHEMOTHERAPY COURSE | 1-gen-2017 | Bassan, R; Masciulli, A; Intermesoli, T; Spinelli, O; Tosi, M; Pavoni, C; Audisio, E; Cattaneo, C; Fumagalli, M; Cassibba, V; Mattei, D; Romani, C; Cortelezzi, A; Ciceri, F; Scattolin, Am; Vitolo, U; Borlenghi, E; Gallamini, A; Depaoli, L; Campiotti, L; Bocchia, M; Di Bona, E; Oldani, E; Rambaldi, A | |
| Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders. | 1-gen-2003 | Passamonti, Francesco; Vanelli, L; Malabarba, L; Rumi, E; Pungolino, E; Malcovati, L; Pascutto, C; Morra, E; Lazzarino, M; Cazzola, M. | |
| Clonal chromosome anomalies and propensity to myeloid malignancies in congenital amegakaryocytic thrombocytopenia (OMIM 604498) | 1-gen-2008 | Maserati, Emanuela; Panarello, C.; Morerio, C.; Valli, Roberto; Pressato, Barbara; Patitucci, F.; Tassano, E.; Di Cesare Merlone, A.; Cugno, C.; Balduini, C. L.; LO CURTO, Francesco; Dufour, C.; Locatelli, F.; Pasquali, Francesco | |
| Conceiving a hematopoietic stem cell donor: twenty-five years after our decision | 1-gen-2012 | G. R., Burgio; Nespoli, Luigi; R., Maccario; A. P., Verri; P., Comoli; M., Zecca | |
| COVID-19 pandemic affects the ability of negative D-dimer to identify venous thromboembolism patients at low risk of recurrence: insights from the Apidulcis study | 1-gen-2023 | Palareti, G.; Legnani, C.; Poli, D.; Ageno, W.; Pengo, V.; Testa, S.; Tosetto, A.; Prandoni, P. | |
| Cytoreductive therapy for patients with essential thrombocythemia at high risk of thromboembolic complications. The difficult choice of the optimal drug | 1-gen-2004 | Passamonti, Francesco; Cazzola, M. | |
| Deep sequencing reveals double mutations in cis of MPL exon 10 in myeloproliferative neoplasms | 1-gen-2011 | Pietra, D; Brisci, A; Rumi, E; Boggi, S; Elena, C; Pietrelli, A; Bordoni, R; Ferrari, M; Passamonti, Francesco; De Bellis, G; Cremonesi, L; Cazzola, M. | |
| EBVD and alternating MOPP/EBVD with or without localized field radiotherapy in advanced or unfavorably presenting Hodgkin's disease. | 1-gen-1996 | Pogliani, Em; Deliliers, Gl; Baldini, L; Tosi, A; Butti, C; Chiorboli, O; Confalonieri, C; Fava, S; Giorgetti, Mc; Maioli, M; Maiolo, At; Marinoni, P; Montalbetti, Lorenzo; Mozzana, R; Pavia, G; Pinotti, G; Rossini, F; Vanoli, P; Venco, Achille; Cassi, E. | |
| EFFICACY OF A IDARUBICIN, ETOPOSIDE AND INTERMEDIATE-DOSE CYTARABINE ARABINOSIDE AS SALVAGE THERAPY IN RELAPSING OR RESISTANT UNFAVORABLE LYMPHOMA | 1-gen-1998 | Brusamolino, E; Passamonti, Francesco; Pagnucco, G; Castagnola, C; Lazzarino, M; Bernasconi, C. | |
| EFFICACY OF PIPOBROMAN IN THE TREATMENT OF POLYCYTHEMIA VERA: LONG TERM RESULTS IN 163 PATIENTS | 1-gen-2000 | Passamonti, Francesco; Brusamolino, E; Lazzarino, M; Barat, C; Klersy, C; Orlandi, E; Canevari, A; Castelli, G; Merante, S; Bernasconi, C. | |
| Erythroleukaemia in early childhood associated with monosomy 7 and defective neutrophil chemotaxis | 1-gen-1982 | Marchi, A.; Sacchi, F.; Ferro, P.; Rubbi, P.; Pasquali, Francesco |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile